Skip to content

Overview

Sequel Pharmaceuticals is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing novel, clinical-stage drug candidates. Sequel intends to grow its drug portfolio through in-licensing of additional cardiovascular drug candidates.